ArticleFrontiers in veterinary science2026
Reference interval for serum amyloid a in apparently healthy donkeys measured with a donkey-specific ELISA.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Serum amyloid A (SAA) is a major acute phase protein used as an inflammatory biomarker in equine medicine. However, no universally accepted assay-specific reference interval (RI) exists for donkeys, and available literature remains limited, with only few studies using different donkey breeds and immunoassay platforms. This study aimed to establish an assay- and population-specific RI for serum SAA in apparently healthy donkeys using a species-specific double sandwich ELISA. Methods: Serum SAA concentrations were measured in 176 apparently healthy donkeys. RI estimation followed ASVCP/CLSI recommendations. The primary RI was calculated nonparametrically as the central 95% interval from all reference individuals, and two-sided 90% confidence intervals (CIs) for the reference limits were estimated nonparametrically. Data were inspected using Tukey's interquartile fences; however, high-end observations were not excluded from the primary RI analysis. Exploratory analyses were performed to assess the need for partitioning by sex, age, or breed. Results: The nonparametric RI for serum SAA was 2.91-42.85 ng/mL. The 90% CI for the lower reference limit was 0.00-4.07 ng/mL, and the 90% CI for the upper reference limit was 35.49-67.10 ng/mL. Exploratory analyses did not support partitioning by sex, age, or breed. The relatively broad CI for the upper reference limit indicated imprecision, likely reflecting the influence of a minority of high-end observations. Discussion: The low SAA concentrations observed in this study are consistent with findings reported in horses. Differences between this and previous donkey studies may reflect variation in assay platform, sample size, management conditions, physiological state, or population characteristics. Because SAA is a rapidly responsive acute phase protein, the proposed interval should be interpreted as an assay- and population-specific RI rather than as a disease-classification decision limit. Clinical interpretation should therefore always consider the individual donkey's clinical context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.